| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10158316 | Biomedicine & Pharmacotherapy | 2018 | 8 Pages |
Abstract
Increased sensitivity of metastatic breast carcinoma cells to NK1R and NK2R antagonists suggest potential therapeutic value of antagonists in metastatic disease. NK1R and NK2R in metastatic breast carcinoma cells react differently to agonists and antagonists. These findings together with previously published data demonstrate that differential consequences of receptor antagonists and SP may inhibit breast cancer growth and metastasis.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Esra Nizam, Nuray Erin,